INCY

NASDAQ

Incyte Corp. · Healthcare · Biotechnology

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$19.15B

PE Ratio

13.4718

EV to Ebitda

9.7461

Earnings Yield

7.42%

Revenue (TTM)

$5.36B

Net Income (TTM)

$1.43B

Revenue (Annual YoY Growth)

21.22%

Revenue (Quarterly YoY Growth)

20.87%

Profit Margin

26.71%

Return on Equity

30.75%

Debt to Equity Ratio

0.007

Dividend Yield

0.00%

All fundamentals

Core10 fields›

Market Cap$19.15B

Revenue TTM$5.36B

Shares Outstanding199.8M

Float221838872

Float Short7.11%

Days To Cover8.1431530209

Short Interest11845858.0

Insider Ownership17.76%

Relative Strength37.6

GARP1240

Growth Estimates17 fields›

Revenue Growth (Annual)21.22%

Revenue Growth (Quarterly YoY)20.87%

Operating Revenue Growth (Annual)0.144609

Operating Revenue Growth (Quarterly YoY)0.124054

3-Year Revenue Growth14.84%

5-Year Revenue Growth14.03%

EPS Growth (Annual)4038.67%

EPS Growth (Quarterly YoY)83.74%

3-Year EPS Growth Rate61.53%

5-Year EPS Growth Rate0.00%

LT EPS Growth Estimates49.56%

EBITDA Growth (Annual)747.76%

EBITDA Growth (Quarterly YoY)45.53%

CFO Growth (Annual)321.52%

CFO Growth (Quarterly YoY)38.82%

FCF Growth (Annual)465.38%

FCF Growth (Quarterly YoY)34.71%

Operations28 fields›

Revenue TTM$5.36B

Gross Margin TTM91.22%

Gross Margin (Quarterly)90.46%

R&D % of Revenue TTM38.77%

R&D Expenses TTM$2.08B

Operating Margin TTM27.05%

Operating Margin (Quarterly)25.47%

Operating Expenses TTM$3.44B

Profit Margin TTM26.71%

Profit Margin (Quarterly)23.83%

Net Income TTM$1.43B

EPS TTM7.0718

EPS (Quarterly)1.4666

EBIT Margin TTM27.05%

EBIT Margin (Quarterly)25.47%

EBITDA Margin TTM28.82%

EBITDA Margin (Quarterly)27.34%

EBITDA TTM$1.54B

CFO % of Revenue TTM27.49%

CFO % of Revenue (Quarterly)29.02%

CFO TTM$1.52B

Cash Margin27.76%

Capex % of Revenue TTM1.79%

Capital Expenditures$95.9M

FCF % of Revenue TTM25.86%

FCF % of Revenue (Quarterly)27.83%

FCF TTM$1.42B

Fundamental Score8

Efficiency6 fields›

ROE30.75%

ROA22.22%

ROIC30.46%

CROCI30.23%

Stock Comp % (Quarterly)5.04%

Stock Comp % TTM4.85%

Valuation21 fields›

P/E (TTM)13.4718

P/E Forward12.3908

P/E Ex-Cash10.6294

P/S Forward3.3856

PEG0.0065

PEG Forward0.6216

P/CFO12.7469

P/FCF13.6072

EV/EBITDA (TTM)9.7461

EV/EBITDA Forward8.3266

EV/Revenues (TTM)2.8086

EV/Revenues Forward2.6783

EV/CFO9.7857

EV/FCF (TTM)10.5968

Price To Book3.385

Price to Tangible Book4.6563

Earnings Yield7.42%

FCF Yield7.35%

Dividend Yield0.00%

Payout Ratio0.00%

Value Score4

Relative to Industry10 fields›

Relative Gross Margin (Quarterly)1.159

Relative P/E0.9196

Relative P/S0.5879

Relative P/B0.7585

Relative Earnings Yield1.0874

Relative Dividend Yield0

Relative ROE0.9217

Relative ROA1.2565

Relative ROIC1.2505

Relative Debt to Equity0.0205

Liquidity15 fields›

Cash Per Share20.0843

Current Ratio3.6816

Cash & ST Assets$4.02B

Total Debt$33.8M

Goodwill & Intangibles$243.2M

Total Assets$7.34B

Total Liabilities$1.72B

Shareholders Equity$5.62B

Debt to Equity0.007

Debt to Assets0.54%

Interest Expense$2.3M

Times Interest Earned620.5293

CFO to Debt (TTM)34.294

Debt to EBITDA (TTM)0.0286

Goodwill % of Assets3.31%

Yields5 fields›

Dividend Yield0.00%

Payout Ratio0.00%

Earnings Yield7.42%

Buyback Yield-1.56%

Shareholder Yield-1.56%

Options Flow8 fields›

Call Volume69

Put Volume37

Put/Call Ratio0.5362318840579711

Call $ Volume25580

Put $ Volume9711

Put/Call $ Ratio0.37963252541047693

Call OI7925

Put OI8671